Blog & News

We have a few things to say about prescription savings.
News

Castlight Health and RazorMetrics Join Forces

AUSTIN, Texas, April 26, 2022/PRNewswire/ – Castlight Health is the newest member of RazorMetrics’ Partnership Collective, and RazorMetrics is joining Castlight’s Ecosystem of leading digital health companies. Castlight, a connected health navigation company, offers a world-class digital platform with a team of clinical and benefits experts who help members easily connect with the right programs and care at the right time, delivering better health outcomes and helping to maximize returns on healthcare investments.

Read More »
Press

Navigating High Drug Costs: Study Finds Consumers Want Their Physician to Lead

RazorMetrics, an innovative healthcare technology company, recently conducted a consumer opinion survey asking about drug costs and found some surprising results. Despite the explosion in consumer-oriented drug savings options – mail-order pharmacy, discount cards, etc. – healthcare consumers want their physician to take the lead on lowering drug costs. The survey found that 80% of respondents would prefer their physician be the one to choose a lower-cost drug for their prescription and do so automatically.

Read More »

RazorMetrics Launches Partnership Collective

The Partnership Collective is comprised of tightly integrated health technology companies with a common goal: drug cost containment and reduction.

Partners in the Collective are benefit management platforms and other types of application providers that count large employers and health plans as clients. RazorMetrics has launched the new initiative to integrate its solution into partners’ technology to seamlessly add drug-cost savings to their existing offerings. Access to the collective will help benefit providers attract new clients and retain current ones by offering a more competitive benefit.

Read More »

Sopris Capital Leads $6,000,000 Series A Investment in RazorMetrics

Sopris Capital, a leading healthcare investment firm, is entering the drug cost transparency space with a new partnership with RazorMetrics, a rapidly growing healthcare technology company focused on lowering pharmacy costs for at-risk employers and health plans. The Series A investment of $6,000,000 was led by Sopris and other individual investors including long-term entrepreneurs Joel Trammell and Jonathan Weiner.

Read More »

Ready to Get Started?

We're Here

To Help You Save

And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.